TY - GEN AU - Cordiali-Fei,P AU - Bianchi,L AU - Bonifati,C AU - Trento,E AU - Ruzzetti,M AU - Francesconi,F AU - Bultrini,S AU - D'Agosto,G AU - Bordignon,V AU - Francavilla,V AU - Tripiciano,A AU - Chiricozzi,A AU - Campione,E AU - Cavallotti,C AU - Orlandi,A AU - Berardesca,E AU - Di Carlo,A AU - Chimenti,S AU - Ensoli,F TI - Immunologic biomarkers for clinical and therapeutic management of psoriasis SN - 1466-1861 PY - 2015///0408 KW - Adalimumab KW - Adult KW - Anti-Inflammatory Agents KW - administration & dosage KW - Antibodies, Monoclonal KW - Antibodies, Monoclonal, Humanized KW - Biomarkers KW - blood KW - Etanercept KW - Female KW - Humans KW - Immunoglobulin G KW - Infliximab KW - Interleukin-6 KW - Interleukins KW - Male KW - Middle Aged KW - Prospective Studies KW - Psoriasis KW - Receptors, Tumor Necrosis Factor KW - T-Lymphocytes, Regulatory KW - metabolism KW - Tumor Necrosis Factor-alpha KW - antagonists & inhibitors KW - Interleukin-22 N1 - Publication Type: Journal Article UR - https://doi.org/10.1155/2014/236060 ER -